Room 4331, 3th building, high-tech industrial park, yizhi road, qingshan district, wuhan, China
Home ProductsHuman Growth Hormone Peptide

Muscle Bodybuilding Sermorelin Acetate 2mg Repair Of Injury

Muscle Bodybuilding Sermorelin Acetate 2mg Repair Of Injury

  • Muscle Bodybuilding Sermorelin Acetate 2mg Repair Of Injury
  • Muscle Bodybuilding Sermorelin Acetate 2mg Repair Of Injury
  • Muscle Bodybuilding Sermorelin Acetate 2mg Repair Of Injury
  • Muscle Bodybuilding Sermorelin Acetate 2mg Repair Of Injury
Muscle Bodybuilding Sermorelin Acetate 2mg Repair Of Injury
Product Details:
Place of Origin: Hubei, China
Brand Name: Bodybiolgical
Certification: ISO9001, SGS
Model Number: Sermorelin
Payment & Shipping Terms:
Minimum Order Quantity: 1kit
Price: USD15/kit
Packaging Details: Foil bag
Delivery Time: 3-7 Days
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 660kits
Contact Now
Detailed Product Description
Product Name: Sermorelin Keywords: Sermorelin Acetate
Specification: 2mg/vial 10vials/kit MOQ: 1kit
Shipping Method: Fedex, TNT, DHL, UPS, HK EMS, EMS, EUB Export Market: USA, UK, Brazil, France, Spain, Thailand
Apperance: White Freezed-dried Powder Policy: Reshipping Policy
Function: Muscle Enhancement, Repair Of Injury Payment Terms: Money Gram, Western Union, Bank Transfer
High Light:

natural hgh supplements


hgh human growth hormone

Repair of Injury Sermorelin Acetate 2mg for Muscle Bodybuilding


Detailed information:

Sermorelin acetate is a synthetic analog of naturally occurring Growth Hormone-Releasing Hormone (GHRH). GHRH is produced in an area of the brain called the hypothalamus from which it is released into blood vessels that carry it to the pituitary gland. Once there, it stimulates production and secretion of growth hormone (GH) which is necessary for growth and development during childhood, as well as for maintenance of normal body composition and metabolism in adults. When GH concentrations are low, deficiency causes poor growth, inadequate muscle and bone development, as well as increased risk for development of intrinsic diseases such as diabetes and other pathologies. Such deficiencies can be opposed by administration of sermorelin which stimulates the pituitary gland to increase output of GH and thereby elevate and restore its serum concentrations to normal levels.

After Roger Guillemin and Andrew Schally were awarded the 1977 Nobel Prize in Medicine for their work on neuroendocrine releasing factors, the precise chemical structure of GHRH, a 44 amino acid peptide, was determined using tissue from human pancreatic tumors that caused acromegaly, a disease resulting from excess secretion of GH.1 The following year, Wehrenberg and Ling2 sought to determine which part of the molecule was essential for its pituitary stimulating action. By eliminating individual amino acids and then testing the remaining peptide fragments, they found that only the first 29 amino acids are needed for stimulating pituitary production and secretion of HGH. Consequently, this fragment of the native molecule, commonly known as Sermorelin is often used to treat GH deficient states in children and adults

Chemically, sermorelin is known as growth hormone releasing factor (GRF) or growth hormone releasing hormone (GRH)1-29 NH2 indicating that the amino terminus is at position 29. However, the molecule is not used clinically as the free base, but rather as the acetic acid salt, i.e. as sermorelin acetate. The free base of sermorelin has the empirical formula C149H246N44O42S and a molecular weight of 3,358 daltons3 Sermorelin acetate is a sterile, non-pyrogenic, lyophilized powder intended for subcutaneous injection after reconstitution with Bacteriostatic Water for Injection and should be stored at between 36 and 46° F (2 and 8° C). Taxonomically, sermorelin is listed as an organic compound (kingdom), an organic acid (superclass), a carboxylic acid (class), amino acid/peptide analogue (subclass), and as a peptide (direct parent).




Growth hormone replacement therapy (GHRT) is a regimen for treating deficiencies in children and adults whose bodies, for one or more reasons fail to produce adequate somatropin (somatotropin, human growth hormone, hGH). This hormonal deficit contributes to poor growth and development in children, and in adults fails to maintain essential aspects of bodily form and function that are needed for a healthy life of normal duration.


The medical condition resulting from inadequate production and/or utilization of hGH is called growth hormone deficiency (GHD).5 Most cases are initially observed as an endocrine disorder in children that occurs equally in males and females, although males are often diagnosed more frequently.67 Because of its significant effect on growth and development as well as causing associated medical problems and reduced quality of life, childhood-onset GHD has been treated with replacement therapy for more than 30 years. In the past, hGH therapy in children affected by GHD was stopped at the time of epiphyseal closure (i.e. at final height). This focus on height originally reflected a measure of successful GH replacement therapy (GHRT) after which treatment was ended. This was done, in part because hGH was originally extracted from human cadavers making its supply fairly limited. However, with advances in technology it became possible to clone the gene capable of producing hGH. Thereafter, the recombinant form of human growth hormone (rhGH) became available in unlimited quantities. Because of its availability for clinical application, rhGH became and is now the drug of choice, not only because of its efficacy, but also because it avoids the risk of transmitting fatal, slow viral (prion-mediated) Creuzfeldt Jacob Disease which was sometimes associated with the cadaver-derived hormone.8 Although originally indicated for use in childhood GHD, rhGH became a licensed indication for GH-deficient adults in the United States, a number of European countries, and New Zealand in 1996. This action was taken because people who had been treated with rhGH as children and then routinely discontinued from treatment upon reaching final height, experienced higher than expected rates of medical problems as adults, beginning in their 30s and 40s. These included reduced physical, mental, and social energy, excess adipose tissue, diminished muscle mass, diminished libido, poor bone density, higher than normal cholesterol levels, and elevated rates of cardiovascular disease. Research trials soon confirmed that a few months of GH replacement therapy could improve nearly all of these parameters in GHD patients. Coincidentally, it was noticed that the same intrinsic diseases as well as maladaptive changes in form and function also occur spontaneously with advancing age.






The dosage depends on the goal. People generally use 2 IU per day for anti aging purposes, between 4 to 6 IU for bodybuilding, weight loss and fitness, between 8 to 16 IU is used for short duration to treat severe burns or recover after injuries.

Doses below 3IU per day usually bring no side effects while people can notice the improvement of their skin, better sleep, more energy, eating junk food without gaining weight, etc.


Many of the body’s systems that function to maintain optimal health and well-being decline with advancing age. Aerobic capacity, muscle mass, and strength all progressively decline with age. Loss of muscle mass, or sarcopenia, and the accompanying reduction in strength increases the risk of falls and their complications, and for many individuals the associated loss of physical, functional capacity leads to increasing difficulty in living independently. Complaints of poor sleep are common in older populations. Insomnia reduces quality of life and is often a factor in decisions to seek health care. Sleep complaints often lead to overmedication and sedation of the elderly, with the numerous potential attendant problems, including increased morbidity and mortality. Finally, cognition also declines with advancing age, particularly those cognitive functions that involve novel problem solving and psychomotor processing speed, with its own related impact on the older individual’s ability to function independently.16 Aging in both sexes is accompanied by profound decreases in GH output and in plasma IGF-I concentrations. This effect is separate from the alterations in body mass index that accompany the normal aging process. Attenuation of GH output associated with aging is related by inference to reduced GH-releasing hormone (GHRH) production, pulse amplitude as well as increased somatostatin (SRIF).


Other Products:


Test prop 100mg/ml~200mg/ml Ripex 225mg/ml
Test enan 250mg/ml ~ 600mg/ml Tritren 180mg/ml
Test cyp 200mg/ml ~ 300mg/ml Tri Test 300mg/ml
Test Sustanon 200mg/ml ~ 400mg/ml Tri Deca 300mg/ml
Deca 200mg/ml 250mg/ml Test Blend 450mg/ml 500mg/ml
Equipoise 200mg/ml 300mg/ml Nandro Test 225mg/ml
Tren ace 100mg/ml 200mg/ml Mass 500mg/ml
Tren enan 100mg/ml 200mg/ml Cut Depot 400mg/ml
Dianabol 50mg/ml Tren Test 225mg/ml
Winstrol 50mg/ml Nandro Test Depot 450mg/ml
Masteron 100mg/ml 150mg/ml Equi Test 450mg/ml
Primobolone 100mg/ml Rip Cut 175mg/ml
Supertest 450mg/ml Tren Test Depot 450mg/ml
Anomass 400mg/ml Brand Contact: Penny


Muscle Bodybuilding Sermorelin Acetate 2mg Repair Of Injury 0


Contact Details
Wuhan Body Biological Co.,Ltd

Contact Person: Penny

Tel: +8613429837396

Send your inquiry directly to us (0 / 3000)

Other Products